Istration trials, which ranged from of 44 -89 (25). Lee et al. (25) suggested
Istration trials, which ranged from of 44 -89 (25). Lee et al. (25) recommended tumor heterogeneity as an explanation for distinct responses towards the similar EGFR-TKI regimen soon after a…